Clinical-epidemiological characterization of patients with lymphoma in a period of ten years in San Cristobal
Keywords:
Hodgkin Lymphoma/epidemiology, Hodgkin Lymphoma/classification, Hodgkin Lymphoma/pathology, Non-Hodgkin Lymphoma/epidemiology, Non-Hodgkin Lymphoma/classification, Non-Hodgkin Lymphoma/pathologyAbstract
Introduction: The mortality of patients due to lymphoma has increased in comparison with the last decade. Objective: Clinically and epidemiologically characterize patients with lymphomas treated in San Cristobal. Methodological design: An observational, descriptive, cross-sectional and retrospective study was conducted between January 2007 and December 2017, which included all the patients treated (n = 65) in the oncohematology service of the General Teaching Hospital Comandante Pinares of the municipality of San Cristobal, in the Artemisa province. Results: The group of 60 and more was the most represented with 30 patients (46.2%), mean age of 55.8 ± 16.1 years. The male sex predominated with 20 patients (30.8%). In both types of lymphomas, the male sex was predominant with 10 (26.3%) with Hodgkin's lymphoma and 20 (73.6%) with non-Hodgkin's lymphoma. Nodular sclerosis was the most frequent variant of Hodgkin's lymphoma with 6 (35.3%) cases. Diffuse large cell non-Hodgkin lymphoma predominated with 9 (18.8%) cases. Stages IIA and I of Hodgkin's lymphoma were the most frequent with 5 (29.4%) and 4 (23.5%) respectively. In patients with non-Hodgkin's lymphoma stage IIA was the most frequent with 13 (20%) patients. The lethality rate of lethality of NHL was 33.8 per 100 patients. Conclusions: The majority of patients presented non-Hodgkin lymphomas, with the male population over sixty years of age being the most affected. The most frequent stages of both varieties were the least advanced, generally of lymph node localization.
References
2. Alonso Mariño OL, Alonso Mariño AL, Miranda ChavianoJ. Caracterización clínico-epidemiológica de los linfomas en un período de cinco años en Villa Clara. Medicentro Electrónica (Internet). 2015 (citado el 15 de marzo de 2018); 19 (1): 13-20. Disponible en: http://scieloprueba.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30432015000100003&lng=es.
3. Eichenauer DE, Engert A, Dile V. Hodgkin lymphoma: clinical manifestations, staging, and therapy. En: Hoffman R, Benz EJ, Silberstein LE, Heslop HE, Weitz JI, Anastasi J. Hematology basic principles and practice. 6th. ed. Philadelphia: Elsevier. 2013. p. 1138-56.
4. Quintanilla-Martínez L. The 2016 updated WHO classification of lymphoid neoplasias. Hematological Oncology (Internet). 2017 (citado el 15 de marzo de 2018); 35 (S1): 37-45. Disponible en: https://onlinelibrary.wiley.com/doi/epdf/10.1002/hon.2399
5. Gómez Codina J, Pastor Borgoñón M. Linfomas no hodgkinianos. En: Cortés-Funes H, Colomer Bosch R. Tratado de Oncología. Barcelona: Permanyer; 2009. p: 589-614.
6. Dirección Nacional de Registros Médicos y Estadísticas de Salud. Incidencia por cáncer en Cuba, 2016. Anuario Estadístico de Salud 2016 (Internet). La Habana: Ministerio de Salud Pública; 2016 (citado el 15 de marzo de 2018). Disponible en: http://files.sld.cu/dne/files/2016/04/anuario-2016-e-sin-graficos1.pdf
7. Guerreiro Hernández Ana María, Villaescusa Blanco Rinaldo, Morera Barrios Luz Mireya, Ramón Rodríguez Luis Gabriel. Manifestaciones autoinmunes en el linfoma no hodgkiniano. Rev Cubana Hematol Inmunol Hemoter (Internet). 2006 (citado el 15 de marzo de 2018) ; 22 (1). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892006000100005&lng=es
8. Díaz Quiñones JA. Los linfomas como neoplasias hematológicas malignas: algunas reflexiones sobre aspectos éticos y sociales. Gac Méd Espirit (Internet). 2014 (citado el 15 de marzo de 2018); 6 (3). Disponible en: http://bvs.sld.cu/revistas/gme/pub/vol.6.(3)_06/p6.html
9. Cabrera ME, García H, Lois V, León A, Peña K, Rossle A, et al. Linfoma de Hodgkin en Chile. Experiencia de 15 años del Programa Nacional de Cáncer del Adulto. Rev Med Chile (Internet). 2007 (citado el 15 de marzo de 2018); 135: 341-50. Disponible en: http://dx.doi.org/10.4067/S0034-98872007000300009
10. Zagoya Martínez P, Vidal Alfredo V. Incidencia de linfoma Hodgkin y no Hodgkin en la población de pacientes del Hospital de Especialidades ISSSTEP, experiencia de 12 años. Rev Hematología. 2013; 14 (1): 165- 6.
11. Verdecia Cañizares C, Santos Labarcena ME, Lam Díaz RM. Comportamiento del linfoma no Hodgkin en la edad pediátrica. Rev Cubana Pediatr (Internet). 2015 (citado 2018 Mar 15); 87 (4): 460-467. Disponible en: http://scieloprueba.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75312015000400008&lng=es.
12. De la Uz Ruesga BO, Hernández Galano GP, Rodríguez Brunet M, Suárez Beyríes LC, Duverger Magdaleón E. Linfomas malignos: datos de un quinquenio en Santiago de Cuba. Medisan (Internet). 2010 (citado el 15 de marzo de 2018); 14 (9). Disponible en: http://bvs.sld.cu/revistas/san/vol_14_9_10/san15910.htm
13. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer (Internet). 2014 (citado el 15 de marzo de 2018); 13: (aprox. 5 p.). Disponible en: http://onlinelibrary.wiley.com/doi/10.1002/ijc.29210/full
14. Pilleux L, Carrasco C, Pisón C, Calderón S. Histología y supervivencia de linfoma no Hodgkin en el Hospital de Valdivia, Chile. Rev Hematol Mex (Internet). 2010 (citado el 15 de marzo de 2018); 11 (4):173- 8. Disponible en: http://www.medigraphic.com/pdfs/hematologia/re-2010/re104c.pdf
15. Bencomo García B, Herrera Rodríguez L. Caracterización clínico epidemiológico de los linfomas en la edad pediátrica en Pinar del Río. 2010-2016. Rev Ciencias Médicas (Internet). 2017 (citado el 15 de marzo de 2018); 21(4): 41-47. Disponible en: http://scieloprueba.sld.cu/scielo.php?script=sci_arttext&pid=S1561-31942017000400007&lng=es.
16. Smith A, Crouch S, Lax S, Li J, Painter D, Howell D, et al. Lymphoma incidence, survival and prevalence 2004–2014: sub-type analyses from the UK's Haematological Malignancy Research Network. Br J Cancer (Internet). 2015 (citado el 15 de marzo de 2018); 112 (9): 1575-1584. Disponible en: https://dx.doi.org/10.1038%2Fbjc.2015.94
Downloads
Published
How to Cite
Issue
Section
License
Those authors who have publications with this journal, accept the following terms:
The authors will retain their copyright and guarantee the journal the right of first publication of your work, which will be under a Creative license Commons Attribution-NonCommercial-ShareAlike 4.0 International . (CC BY-NC-SA 4.0).
The authors may adopt other non-exclusive license agreements for the distribution of the published version of the work (eg:deposit it in an institutional telemat
